Insider trades

Richard Mulligan, Director of Sana Biotechnology SANA, has filed 0 purchases and 2 sales on the open market. The latest trade was on 06/04.

Richard Mulligan

Director
First filing
23/03/03
Trades
14 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
06/04

Trading activity

Transactions

Trade type
SANA
Open-market sale10b5-1 plan24/09/24–24/09/2524/09/26300,000 sh2 trades$3.99avg.$1,195,500−10.0%